semaglutide glp-1 Another Weight-Loss Trial Win for Weekly Drug Compounded GLP-1 - Semaglutide &
Description
The challenge now is to balance that principle
Why it matters: GLP-1 drug costs to public and commercial insurance are soaring
Attempts should be made to control preprandial blood glucose with basal/slow-acting insulins first, and then to control post-prandial blood glucose with rapid-acting insulin
For data modelling, the key point is that brand, molecule, dose, indication, and reimbursement status should not be collapsed into one undifferentiated field
